Cytosorbents
CTSO
#10585
Rank
S$29.07 M
Marketcap
S$0.46
Share price
3.08%
Change (1 day)
-58.73%
Change (1 year)

Cytosorbents (CTSO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$49.18 Million

According to Cytosorbents's latest financial reports the company's total liabilities are S$49.18 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cytosorbents - Total liabilities on balance sheet (from 2005 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$49.14 M-0.3%
2024-12-31S$49.29 M26.63%
2023-12-31S$38.92 M4.24%
2022-12-31S$37.34 M2.53%
2021-12-31S$36.42 M156.46%
2020-12-31S$14.2 M-56.04%
2019-12-31S$32.3 M37%
2018-12-31S$23.58 M27.39%
2017-12-31S$18.51 M53.06%
2016-12-31S$12.09 M180.9%
2015-12-31S$4.3 M-27.68%
2014-12-31S$5.95 M-74.34%
2013-12-31S$23.2 M26.78%
2012-12-31S$18.3 M15.71%
2011-12-31S$15.81 M434.65%
2010-12-31S$2.95 M117.06%
2009-12-31S$1.36 M-7.27%
2008-12-31S$1.46 M12.62%
2007-12-31S$1.3 M-21.35%
2006-12-31S$1.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Boston Scientific
BSX
S$23.38 B 47,457.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$5.04 B 10,157.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
S$0.12 B 147.70%๐Ÿ‡บ๐Ÿ‡ธ USA